Evaluation of DNA methylation levels of <i>SEPT9</i> and <i>SHOX2</i> in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR-Reference-Cited by-同舟云学术

Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR

Published:2024-01-31 Issue:3 Volume:51 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Grossi Ilaria¹,Assoni Claudia²,Lorini Luigi²,Smussi Davide²,Gurizzan Cristina²,Grisanti Salvatore²,Paderno Alberto³,Mattavelli Davide³,Piazza Cesare³,Pelisenco Iulia¹,De Petro Giuseppina¹,Salvi Alessandro¹,Bossi Paolo²

Affiliation:

1. Division of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia, I‑25123 Brescia, Italy

2. Unit of Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, I‑25123 Brescia, Italy

3. Unit of Otorhinolaryngology‑Head and Neck Surgery, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, I‑25123 Brescia, Italy

Publisher

Spandidos Publications

Reference49 articles.

1. Head and neck cancer;Mody;Lancet,2021

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma;Barsouk;Med Sci (Basel),2023

4. Recent advances and future directions in clinical management of head and neck squamous cell carcinoma;Muzaffar;Cancers (Basel),2021

5. Circulating tumor DNA as a cancer biomarker: An overview of biological features and factors that may impact on ctDNA analysis;Sánchez-Herrero;Front Oncol,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SEPT9: From pan-cancer to lung squamous cell carcinoma;BMC Cancer;2024-09-05